Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Prudential Financial Inc (PRU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs Prudential Financial Inc — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.62 (market cap $6.04B), while Prudential Financial Inc trades at $113.09 (market cap $39.17B). The key difference: Prudential Financial Inc is far larger — about 6.5× Iovance Biotherapeutics Inc. Common Stock's market cap, and Prudential Financial Inc pays a 4.93% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Prudential Financial Inc for 145 Days on average.
| IOVA | PRU | |
|---|---|---|
Market Cap | $6.04B | $39.17B |
Volume | 14,805,993 | 1,436,917 |
Sector | Health | Financials |
52-Week High | $14.82 | $125.13 |
52-Week Low | $1.81 | $92.00 |
Typical Hold Time | 0 Days | 145 Days |
Enterprise Value | $5.97B | $67.95B |
Dividend Yield | — | 4.93% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Prudential Financial (PRU) trades at $113.53, up 1.04% with mixed technical signals showing bearish moving averages but neutral oscillators. The company demonstrates solid fundamentals with a P/E of 10.29 and ROE of 12.46%, while recent earnings show two consecutive beats. Strategic moves include the Alexforbes stake sale and rebranding to Prudential Wealth Advisors, reflecting focus on core operations.
PRU presents a value opportunity with attractive valuation metrics, though analyst consensus is cautious with 67.57% hold ratings. Key risks include interest rate sensitivity and execution of the $3B capital rotation plan. The stock trades above the $105.67 consensus target, suggesting limited near-term upside despite strong annuity market positioning.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About Prudential Financial Inc
Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →
